ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2849

Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis

Patricia Katz1, Sofia Pedro2 and Kaleb Michaud2,3, 1University of California San Francisco, San Francisco, CA, 2FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, 3Rheumatology, University of Nebraska Medical Center, Omaha, NE

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA) and sleep apnea

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Session Title: 5T099 ARHP Abstract: Clinical Aspects & Outcomes Research–ARHP II (2844–2849)

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Self-reported sleep disturbances (SDs) are common in RA. Most studies of sleep in RA have focused on SDs in general. Obstructive sleep apnea (OSA) is one specific type of SD, which has well characterized negative health effects and for which treatment is available. We examined the frequency OSA symptoms, risk, diagnosis, and treatment, and factors associated with OSA risk.

Methods: Data were from Forward – The National Databank for Rheumatic Diseases, for which participants complete questionnaires every 6 months. RA diagnoses were physician-reported. In one questionnaire, items about the presence of symptoms, physician diagnoses (MD-DX), and treatment of OSA were included. Risk of OSA was assessed using a validated questionnaire with positive predictive value of ~85%1. Items included snoring, daytime sleepiness, observations of apnea episodes by others, presence/treatment of hypertension (Table 1). Presence of ≥2 of these symptoms plus age>50 or BMI >35 indicates high risk for OSA. Use of continuous positive air pressure (CPAP) devices were also assessed. Frequencies of OSA symptoms, risk, diagnosis, and treatment were tabulated. Multivariate logistic regression analyses identified independent predictors of high risk of OSA. Potential predictors included age, sex, smoking, low income, chronic obstructive pulmonary disease (COPD), other comorbid conditions, obesity, disease duration, self-reported RA disease activity (RA Disease Activity Index, RADAI), medications, and pain.

Results: Subject characteristics and prevalence of OSA symptoms are shown in Table 1 (n = 2623). 16% reported MD-DX OSA and an additional 8% were at high risk of OSA, compared to OSA prevalence of ~2-4% in the general population. 9% used CPAP (58% of MD-DX OSA; 34% of those at high risk for OSA). Independent predictors of OSA risk were obesity, smoking, more comorbid conditions, and RADAI (Table 2).

Conclusion: OSA was more common in RA than in the population, with only 2/3 of those at high risk reporting an OSA diagnosis. Half of those with a diagnosis reported treatment. Some predictors of OSA were similar to predictors in the population (age, obesity), but disease activity was also associated with OSA. Self-reported sleep problems are associated with poor RA disease outcomes. In other conditions, OSA is linked to heightened inflammation, so it could be a cause of increased RA disease activity. Further research is needed to tease out disease-specific causes and effects of OSA and other sleep disturbances in RA.

1 Chung F et al: Anesthesiol 2008;108:812; J Clin Sleep Med 2014;10:951

Table 1. Subject characteristics (n = 2639)

Mean +/- SD or % (n)

Mean +/- SD or % (n)

Sociodemographic

Age, years

67.2 +/- 11.4

Female

82.7 (2168)

White

93.4 (2465)

Low income

25.4 (687)

General health

Current smoker

3.6 (94)

Obese (BMI≥30)

32.1 (861)

Rheumatic Disease Comorbidity Index2

2.1 +/- 1.7

Morbid obesity (BMI≥35)

15.3 (402)

COPD

7.9 (208)

RA characteristics

RA duration, years

23.0 +/- 12.8

Prednisone use

25.2 (657)

Pain rating (0 – 10)

3.2 +/- 2.5

Biologic use

51.5 (1349)

RA Disease Activity Index (RADAI)

2.2 +/- 1.5

Function (HAQ; Health Assessment Questionnaire)

0.98 +/- 0.73

Obstructive sleep apnea risk factors1

Snoring: do you snore loudly (loud enough to be heard through closed doors)?

12.0 (311)

Daytime sleepiness: do you often feel sleepy during the daytime (such as falling asleep during driving or while talking to someone)?

11.9 (310)

Observed apnea episodes: Has anyone observed you stop breathing or choking/gasping during your sleep?

13.1 (341)

Hypertension: do you have or are you being treated for high blood pressure?

31.3 (821)

2 England BR. Arthritis Care Res 2015; 6: 865

Table 2. Significant predictors of Obstructive Sleep Apnea (OSA)*

High risk OSA

Bivariate

Multivariate

 

Age

0.99 (0.98, 1.00

ns

 

Female

0.6 (0.5, 0.8)

0.6 (0.4, 0.8)

 

RDCI

1.3 (1.3, 1.4)

1.2 (1.1, 1.3)

 

COPD

2.4 (1.7, 3.3)

ns

 

Obese

3.3 (2.7, 4.2)

2.6 (2.1, 3.4)

 

Current smoking

2.2 (1.3, 3.5)

1.7 (1.0, 2.8)

 

Low income

1.3 (1.0, 1.7)

ns

 

RA duration

0.99 (0.98, 1.0)

ns

 

RADAI

1.5 (1.4, 1.6)

1.4 (1.2, 1.6)

 

Pain rating

1.2 (1.2, 1.3)

ns

 

Biologic use

1.0 (0.8, 1.2)

ns

 

Prednisone use

1.3 (1.0, 1.7)

ns

 

* Tabled values are odds ratio (95% CI) from multiple logistic regression analyses


Disclosure: P. Katz, Bristol-Myers Squibb, 2; S. Pedro, None; K. Michaud, None.

To cite this abstract in AMA style:

Katz P, Pedro S, Michaud K. Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/risk-of-obstructive-sleep-apnea-in-rheumatoid-arthritis/. Accessed August 12, 2022.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-obstructive-sleep-apnea-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies